Online citations, reference lists, and bibliographies.
← Back to Search

Blepharospasm And Orofacial‐cervical Dystonia: Clinical And Pharmacological Findings In 100 Patients

J. Jankovic, J. Ford
Published 1983 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We evaluated prospectively 100 patients, the largest reported series, with blepharospasm and orofacial‐cervical dystonia, or Meige syndrome. The mean age at onset was 51.7 years, and 81% presented between the ages of 40 and 70. Women outnumbered men three to two. Blepharospasm was the initial symptom in 58 patients, but only 23 had involuntary movements localized to the orbicularis oculi. Sixty‐one patients had the complete syndrome, blepharospasm and oromandibular dystonia, and 60 had neck or generalized dystonia in addition to the orofacial movements. Twenty‐one patients with spasmodic dysphonia were included; in 12 of these patients, spasmodic dysphonia was part of the complete (Meige) syndrome, and 16 of these patients had neck or generalized dystonia or essential tremor. An organic cause of Meige syndrome is supported by a high correlation with essential tremor and other movement disorders and by positive family history in some patients. Response to medication was inconsistent, but 69% of patient trials resulted in some improvement; in 22% the benefit was marked and persistent. Tetrabenazine, lithium, and trihexyphenidyl were most useful for the treatment of oromandibular dystonia, and clonazepam was useful in some patients with blepharospasm.
This paper references
10.1136/jnnp.44.5.437
Brueghel's syndrome, report of a case with postmortem studies
E. García-Albea (1981)
10.1016/S0033-3182(79)73723-6
Lithium carbonate: a therapeutic agent for spasmodic torticollis.
H. Sachdev (1979)
10.1212/WNL.30.4.349
Spastic dysphonia and Meige disease
D. Jacome (1980)
10.1097/00007611-198007000-00009
Meige's Syndrome
T. Ashizawa (1980)
10.1212/WNL.32.10.1202
Spastic dysphonia, Meige disease, and torsion dystonia
C. Marsden (1982)
10.1111/j.1600-0404.1977.tb01431.x
SPONTANEOUS BUCCOLINGUOFACIAL DYSKINESIA IN THE ELDERLY
P. Delwaide (1977)
10.1212/WNL.30.7.690
Pharmacology of blepharospasm‐oromandibular dystonia syndrome
D. Casey (1980)
10.1002/ANA.410120308
Tetrabenazine has properties of a dopamine receptor antagonist
I. Login (1982)
10.1212/WNL.31.10.1235
Quantitative assessment of parkinsonian and essential tremor
J. Jankovic (1981)
10.1136/jnnp.39.12.1204
Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?
C. Marsden (1976)
10.1016/S0002-9394(14)74687-2
Essential Blepharospasm. A Review of Medical Management and A Therapeutic Trial of Choline Chloride
J. B. Skarf (1981)
10.1002/ANA.410050418
Blepharospasm: Successful treatment with clonazepam
J. R. Merikangas (1979)
10.1001/ARCHNEUR.1979.00500460069010
Meiges disease: a clinical form of facial convulsion, bilateral and medial.
E. Tolosa (1979)
10.1016/0022-510X(68)90094-4
Mouthing in the elderly: a cerebellar sign.
O. Appenzeller (1968)
10.1002/ANA.410110108
Treatment of hyperkinetic movement disorders with tetrabenazine: A double‐blind crossover study
J. Jankovic (1982)
10.1111/j.1600-0447.1977.tb00226.x
Loxapine versus haloperidol parenterally in acute psychosis with agitation
K. Fruensgaard (1977)
10.1212/WNL.32.12.1335
Tardive dystonia
R. Burke (1982)
10.1001/ARCHNEUR.1972.00490120046004
Spontaneous oral-facial dyskinesia.
P. Altrocchi (1972)
10.1001/JAMA.1982.03330230060037
Blinking and blepharospasm. Mechanism, diagnosis, and management.
J. Jankovic (1982)
10.1002/ANA.410110123
Lithium therapy in torsion dystonia
J. F. Marti‐Masso (1982)
10.1159/000153182
Cohort study of opportunity for selection on two Swedish 19th century parishes with a survey of other estimates.
H. Hed (1981)
10.1001/ARCHNEUR.1974.00490410100014
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
H. Pakkenberg (1974)
10.7326/0003-4819-94-6-788
Drug-induced and other orofacial-cervical dyskinesias.
J. Jankovic (1981)
10.1212/WNL.29.8.1126
Meige disease
E. Tolosa (1979)
Meige's syndrome. Dyskinesia of the eyelids and facial muscles.
Paulson Gw (1972)
10.1001/JAMA.1971.03180350037008
Orofacial dyskinesia. A dental dimension.
H. Sutcher (1971)
10.1001/ARCHNEUR.1981.00510030041005
Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases.
E. Tolosa (1981)
10.1002/ANA.410090214
Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters
J. Nutt (1981)
10.1212/WNL.31.12.1555
Meige syndrome (blepharospasm‐oromandibular dystonia) after long‐term neuroleptic therapy
W. Weiner (1981)
10.1056/nejm197507102930215
Letter: Dimethyl aminoethanol in blepharospasm and hemifacial spasm.
M. P. Dahdaleh (1975)



This paper is referenced by
10.1002/MDS.870090110
Variable onset of adult inherited focal dystonia: A problem for genetic studies
S. Micheli (1994)
10.1016/S1079-2104(99)70006-5
Customized EMG needle insertion guide for the muscle afferent block of jaw-deviation and jaw-opening dystonias.
K. Yoshida (1999)
10.1007/S11940-000-0037-7
Blepharospasm and hemifacial spasm
D. Boghen (2000)
MEIGE , S SYNDROME
N. Majdinasab (2010)
10.1002/MDS.870010107
Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem– thalamic lesion: Structural and functional abnormalities studied with CT, MRI, and PET scanning
K. Leenders (1986)
10.1016/B978-0-12-089445-1.50024-2
20 – Clinical aspects and treatment of cranial movement disorders
J. Jankovic (1990)
10.1136/BJO.75.12.737
Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.
J. Mauriello (1991)
10.3171/2017.7.JNS17323
Long-term outcome of pallidal stimulation for Meige syndrome.
S. Horisawa (2018)
Parkinsonism and Related Disorders
B. Borroni (2016)
10.1186/2054-7072-1-3
The phenomenology and natural history of idiopathic lower cranial dystonia
P. Termsarasab (2014)
10.1007/978-1-60327-426-5_48
Orofacial Dystonia with Lower Facial and Platysma Dystonia
Roongroj Bhidayasiri (2012)
10.1016/0303-8467(94)90072-8
Idiopathic spasmodic torticollis: a survey of the clinical syndromes and patients' experiences
G. M. F. M. V. Herwaarden (1994)
10.1002/MDS.870060422
Blepharospasm associated with pseudohypoparathyroidism and bilateral basal ganglia calcifications
O. Blin (1991)
10.1111/j.1755-3768.1990.tb01933.x
Long‐term treatment of involuntary facial spasms using botulinum toxin
P. Ruusuvaara (1990)
10.1007/S11724-009-0131-X
Douleur orofaciale et désordres oromoteurs
P. Blanchet (2009)
10.1136/jnnp-2013-305532
The treatment of dystonic tremor: a systematic review
A. Fasano (2013)
10.1111/j.1440-1819.1989.tb03097.x
Meige's Syndrome during Long‐Term Neuroleptic Treatment
K. Kurata (1989)
10.1002/MDS.870060217
Isolated lingual/palatal dystonia
D. E. Robertson-Hoffman (1991)
10.1136/jnnp.60.2.204
Sex prevalence of focal dystonias.
V. Soland (1996)
10.1136/jnnp.74.2.265
Does sex influence age at onset in cranial-cervical and upper limb dystonia?
G. Defazio (2003)
10.1002/MDS.870131310
Epidemiology and Genetics of Essential Tremor
M. Brin (1998)
10.4317/MEDORAL.16.E96
Lateral pterygoid muscle dystonia. A new technique for treatment with botulinum toxin guided by electromyography and arthroscopy.
P. Martos-Díaz (2011)
primary progressive multiple sclerosis The effect of interferon beta-1 a on spasticity in
S. Leary (2004)
10.1007/BF00867421
A genetic study of idiopathic focal dystonias
M. Stojanovic (2004)
10.1179/crn.2004.041
Treatment of Inferior Lateral Pterygoid Muscle Dystonia with Zolpidem Tartrate, Botulinum Toxin Injections, and Physical Self-Regulation Procedures: A Case Report
E. Vázquez-Delgado (2004)
10.1001/ARCHOPHT.1984.01040031028013
Essential blepharospasm and the Meige syndrome.
S. Dresner (1984)
10.1002/MDS.870050107
Effect of intravenous injection of biperiden and clonazepam in dystonia
U. J. Povlsen (1990)
10.1176/JNP.4.4.435
Bipolar disorder in idiopathic dystonia: clinical features and possible neurobiology.
E. Lauterbach (1992)
10.1001/ARCHOPHT.1997.01100150633010
The role of blink adaptation in the pathophysiology of benign essential blepharospasm.
S. A. Hasan (1997)
10.11261/IRYO1946.55.195
4. 多系統萎縮症(MSA)での異常表情と抗パーキンソン病剤との関係
正明 小長谷 (2001)
10.1177/1756285614557475
Botulinum toxin in the management of blepharospasm: current evidence and recent developments
Amy M Hellman (2015)
10.1016/j.parkreldis.2016.10.022
Mild parkinsonian features in dystonia: Literature review, mechanisms and clinical perspectives.
L. Haggstrom (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar